Increased Levels of Soluble CD206 Associated with Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis
Objective. Soluble CD206 (sCD206) is considered a macrophage activation marker, and a previous study proved it as a potential biomarker to predict the severity of anti-melanoma differentiation-associated gene 5- (anti-MDA-5-) positive dermatomyositis- (DM-) associated interstitial lung disease (ILD)...
Saved in:
Main Authors: | Ya-Wen Shen (Author), Ya-Mei Zhang (Author), Zhen-Guo Huang (Author), Guo-Chun Wang (Author), Qing-Lin Peng (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease
by: Wang K, et al.
Published: (2022) -
Rapidly progressive interstitial lung disease associated with dermatomyositis-Longitudinal course of anti‐MDA5 antibody titer in two cases
by: Kentaro Awaji, et al.
Published: (2021) -
Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis
by: Rachot Wongjirattikarn, et al.
Published: (2020) -
Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report
by: Walter Conca, et al.
Published: (2020) -
Successful tocilizumab treatment for rapidly progressive interstitial lung disease with anti-MDA5-positive juvenile dermatomyositis: a case report and literature review
by: Lingzhi Qiu, et al.
Published: (2024)